FDA Approves First Treatment for Pompe Disease The Food and
FDA Approves First Treatment for Pompe Disease
The Food and Drug Administration approved a biologics license application (BLA) for Myozyme (alglucosidase alfa, rhGAA), the first treatment for patients with Pompe disease, a rare but severely debilitating disease.